Jérôme Augustin is Appointed as CEO of NextKidney
NeoKidney and Debiotech have announced that they are joining forces to form NextKidney SA in order to finalize the development as well as commercialization of the NeoKidney, a portable, user-friendly home hemodialysis device. Jérôme Augustin has been named the company’s CEO and is tasked with bringing the NeoKidney to market introduction. NextKidney will benefit from both the technical skills brought by Debiotech and from the network of patients, healthcare practitioners, and health insurance companies, developed by Neokidney BV and the Dutch Kidney Foundation. Mr. Augustin has over a decades experience in developing and launching medical devices. He previously served as the Co-founder and CEO of Physidia and also held leadership positions at Boston Scientific, American Medical Systems and Merz Pharmaceuticals. "Joining NextKidney today means taking the lead of an exceptional team and together transforming an elegant technology into a truly revolutionary product. This is a mission that I am proud to take on" said Mr. Augustin.